Skip to main content
Andrew Feigin, MD, Neurology, New York, NY, NYU Langone Hospitals

AndrewSFeiginMD

Neurology New York, NY

Professor, Neurology, NYU Langone Health

Dr. Feigin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Feigin's full profile

Already have an account?

Education & Training

  • University of Rochester
    University of RochesterResidency, Neurology, 1989 - 1992
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1988 - 1989
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1992 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AAN 2023: Pridopidine Phase 3 Trial Misses Goal, but Benefits Seen for Some
    AAN 2023: Pridopidine Phase 3 Trial Misses Goal, but Benefits Seen for SomeMay 2nd, 2023
  • Prilenia Shares Preliminary Topline Results from Phase 3 PROOF-HD Clinical Trial in Huntington's Disease and Data from Phase 2 HEALEY ALS Platform Trial of Pridopidine at the 75th American Academy of Neurology (AAN) Annual Meeting
    Prilenia Shares Preliminary Topline Results from Phase 3 PROOF-HD Clinical Trial in Huntington's Disease and Data from Phase 2 HEALEY ALS Platform Trial of Pridopidine at the 75th American Academy of Neurology (AAN) Annual MeetingApril 25th, 2023
  • Parkinson’s Cases May Be 50% Higher Than Previously Thought: Why That’s Important to Know
    Parkinson’s Cases May Be 50% Higher Than Previously Thought: Why That’s Important to KnowDecember 15th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations